Cargando…
LINC-PINT suppresses cisplatin resistance in gastric cancer by inhibiting autophagy activation via epigenetic silencing of ATG5 by EZH2
Resistance to cisplatin (DDP) is a major obstacle in the clinical treatment of advanced gastric cancer (GC). Long noncoding RNA (lncRNA) play a significant regulatory role in the development and drug resistance of GC. In this study, we reported that the lncRNA LINC-PINT was downregulated in DDP-resi...
Autores principales: | Zhang, Cheng, Kang, Tong, Wang, Xinyi, Wang, Jizhao, Liu, Lin, Zhang, Jiawei, Liu, Xu, Li, Rong, Wang, Jiansheng, Zhang, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452659/ https://www.ncbi.nlm.nih.gov/pubmed/36091809 http://dx.doi.org/10.3389/fphar.2022.968223 |
Ejemplares similares
-
Pint lincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2
por: Marín-Béjar, Oskar, et al.
Publicado: (2013) -
Long Non-coding RNA LINC-PINT Suppresses Cell Proliferation and Migration of Melanoma via Recruiting EZH2
por: Xu, Yangfan, et al.
Publicado: (2019) -
Long noncoding RNA LINC-PINT promotes proliferation through EZH2 and predicts poor prognosis in clear cell renal cell carcinoma
por: Duan, Junyao, et al.
Publicado: (2019) -
Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer
por: Li, Le, et al.
Publicado: (2016) -
Clinical implications of lncRNA LINC-PINT in cancer
por: Bukhari, Ihtisham, et al.
Publicado: (2023)